[1] Mustaesa S.Developmentofitew vaccines and diagnostic reagents against tuberculosis[J].Molecular Immunology,2002,39:113-119.
[2] Lowrie D B,Tasconr E,Bonatovl D,et al.Therapy of tubercu-losis in mice by DNA vaccination[J].Nature,1999,400:269-271.
[3] 师长宏,范雄林,柏银兰,等.结核分枝杆菌Ag85B-ESAT6融合蛋白在小鼠体内诱导的免疫应答及其保护力[J].第四军医大学学报,2004,25(18):1633-1636.
[4] 师长宏,安家泽,唐小凤,等.结核分枝杆菌MPT64-ESAT6融合蛋白在小鼠内诱导的免疫应答及其保护力[J].第四军医大学学报,2006,27(9):769-771.
[5] Paton D J,Valarcher J F,Bergnmnn I,et al.Selection of foot and mouth disease vaccine strains-a review[J].Rev Sci Tech,2005,24.
[6] Kaufmann S H E.Heat shock proteins and the immune re-sponse[J].Immunol Today,1990,11(1):129-136.
[7] Johansen P,Raynaud C,Yang M,et al.Anti-mycobacterial immunity induced by a singh injection of M.leprae HSP65-encoding plasmid DNA inbiodegradable microparticles[J].Inununol Lett,2003,90(2-3):81-85.
[8] Trajkovic V,Natarajan K,Sharma P.Immunomodulatory ac-tion of mycobacterial secretory proteins[J].Microbes Infect 2004,6(5):513-519.
[9] Lowrie D B,Tascon R E,Colston M J,et al.Towards a DNA vaccine against tuberculosis[J].Vaccine,1994,12:1537-1540.
[10] Ravn P,Demissie A,Eguale T,et al.Human T cell response to the ESAT-6 antigen from Mycobacterium tuberculosis[J].J Infect Dis,1999,179:637-645.
[11] Hongxun S,Vladimir M P,Corey M,et al.Regiona,I but not systemicrecroitment,expansion of dendritic cells by a pluron-ic-formulated Flt3-ligand plasmid with vaccine adjuvant ac-tivity[J].Vaccine,2003,21(26):3019-3020.
[12] 李林,佳飞.转基因植物口服疫苗的免疫机制研究进展[J].国外医学免疫学分册,2004,27(6):354-357.
[13] 郝浩永,尉亚辉.转基因番茄表达121服乙肝疫苗[J].食品科学,2007,28(6):201-204.
[14] 陈珍,陈文莉.转基因植物口服疫苗研究的新进展[J].细胞与分子免疫学杂志,2006,22(6):831-833. |